1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING INCIDENCES OF CARDIAC DISORDERS
6.1.2 TECHNOLOGICAL ADVANCEMENT
6.2 MARKET RESTRAINTS
6.2.1 RISK ASSOCIATED WITH ECMO TREATMENT
6.2.2 HIGH COST OF THE ECMO PROCEDURE
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 BY APPLICATION
7.1.1 CARDIAC
7.1.2 RESPIRATORY
7.1.3 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
7.2 BY MODALITY
7.2.1 VENO-ARTERIAL
7.2.2 VENO-VENOUS
7.2.3 ARTERIO-VENOUS
7.3 BY GEOGRAPHY
7.3.1 NORTH AMERICA
7.3.1.1 US
7.3.1.2 CANADA
7.3.1.3 MEXICO
7.3.2 EUROPE
7.3.2.1 FRANCE
7.3.2.2 UK
7.3.2.3 GERMANY
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF EUROPE
7.3.3 ASIA-PACIFIC
7.3.3.1 INDIA
7.3.3.2 CHINA
7.3.3.3 JAPAN
7.3.3.4 AUSTRALIA
7.3.3.5 SOUTH KOREA
7.3.3.6 REST OF APAC
7.3.4 MIDDLE EAST AND AFRICA
7.3.4.1 GCC
7.3.4.2 SOUTH AFRICA
7.3.4.3 REST OF MIDDLE EAST AND AFRICA
7.3.5 SOUTH AMERICA
7.3.5.1 BRAZIL
7.3.5.2 ARGENTINA
7.3.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.1 MEDTRONIC
9.2 NIPRO
9.3 ALUNG TECHNOLOGIES INC
9.4 TERUMO
9.5 MICROPORT SCIENTIFIC CORPORATION
9.6 LIVANOVA PLC
9.7 OTHERS
10. FUTURE OUTLOOK OF THE MARKET

MEDTRONIC
NIPRO
ALUNG TECHNOLOGIES INC
TERUMO
MICROPORT SCIENTIFIC CORPORATION
LIVANOVA PLC